	Case Report: Non-traumatic splenic rupture as the first presentation of diffuse large B-cell lymphoma complicated by clinically diagnosed pulmonary aspergillosis supported by metagenomic next-generation sequencing. Front Med (Lausanne) Zhao Y, Duan J. PMID: 42661655 [PubMed]
	Venetoclax for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: Prospects, resistance mechanisms and management strategies. Clin Transl Med Zhang J, Liu J, Zhao M, Zhang X, Liu L, Li M, Cao C, Zhang R, Zhao M. PMID: 42661469 [PubMed - indexed for MEDLINE]
	Case Report and Retrospective Review of Acanthamoeba Encephalitis and Chronic Lymphocytic Leukemia, United States. Emerg Infect Dis Persico M, Haston JC, Imada E, Kasten J, Pimentel C, Collins JM. PMID: 42661277 [PubMed - indexed for MEDLINE]
	Hematological Malignancy Trials in Chinese Mainland, 2013-2022: A Landscape Analysis with Exploratory Macro-Level Temporal Correlations. Clin Transl Sci Qi J, Gao J, Huang Z, Li B, Yue Y, Liu L, Xu M, Huang L, Chen S, Ji Q, Song Z, Shen Q, Ma S, Yi S, Wang X, Cheng T, Shi L, Zhang L. PMID: 42661250 [PubMed - indexed for MEDLINE]
	Plasma Dimethylarginine Concentrations in Dogs With Large Cell Lymphoma or Hemangiosarcoma: A Prospective Observational Study. Vet Comp Oncol Marques GB, Maurey C, Le Roux D, Béguin J. PMID: 42661152 [PubMed - as supplied by publisher]
	Novel case of cytoplasmic CD3 positive, surface CD4 positive high-grade B-cell lymphoma with MYC rearrangement. J Hematop Miltchev V, Golardi N. PMID: 42661005 [PubMed - indexed for MEDLINE]
	Longitudinal characterization of mosaic chromosomal alterations identifies factors influencing clonal dynamics of leukocytes. Nat Commun Kelly RL, Brown DW, Zhou W, Hubbard AK, Young CD, Barnao KM, Klein A, Dutta D, Vogt A, Liu J, Wang J, Huang WY, Freedman ND, Chanock SJ, Albert PS, Machiela MJ. PMID: 42660912 [PubMed - indexed for MEDLINE]
	Spatial Lineage Divergence at Diagnosis in a Pediatric KMT2A-Rearranged Leukemia Presenting with Concurrent AML and B-LBL. Pediatr Dev Pathol Zhang H, Miao Q, Wang Y, Li L, Yi M, Jiang X. PMID: 42660826 [PubMed - as supplied by publisher]
	Advances in differentiation syndrome in acute promyelocytic leukemia: From mechanisms to management. Blood Rev Han S, Zhao Y, Su Y, Wang Y, Wang D, Xing X. PMID: 42660706 [PubMed - as supplied by publisher]
	Morphologic Correlates of Genetic Subtypes of Acute Myeloid Leukemia. Hum Pathol Anderson-Calleja J, Ehyaee V, Mirza KM. PMID: 42660296 [PubMed - as supplied by publisher]
	Beyond maximum grade: key regulatory considerations in adverse event reporting. Lancet Haematol Tzogani K, El-Galaly TC, Everest N, Gisselbrecht C, Mitsuiki N, Nagai S, Thompson R, Thanarajasingam G. PMID: 42660133 [PubMed - indexed for MEDLINE]
	Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies. Lancet Haematol Wästerlid T, Valcarcel BS, Presno D, Stemmelin G, Plate A, Syriopoulou E, Stubblefield MD, Morton LM, Matasar M, Thanarajasingam G, Smedby KE. PMID: 42660132 [PubMed - indexed for MEDLINE]
	CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study. Lancet Haematol Kersten MJ, Kuipers MT, Mutsaers PGNJ, Willems E, Saevels K, Dreyling M, Jacobson C, Bishop MR, Zandvliet M, Milatos S, Lobetti-Bodoni C, Blum S, Van Hoorde K, Desai J, Acciarri L, Pont MJ, van Muyden A, Fasan O, Vermaat JSP, Anguille S. PMID: 42660131 [PubMed - indexed for MEDLINE]
	Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial. Lancet Haematol Falchi L, Vermaat JSP, Brody JD, Leslie L, Offner F, Christensen JH, Nijland M, Belada D, Wahlin BE, Drott K, Gomez Prieto P, Kope, García-Sancho AM, Mei JP, Alt, Risum M, Reilly A, Zou J, Abrisqueta P. PMID: 42660129 [PubMed - indexed for MEDLINE]
	Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes. Eur J Cancer Diekmann B, Woolthuis CM, Corsten MF, de Leeuw D, Fiets RB, Segarceanu E, van der Valk FM, de Waal TT, Cruijsen M, de Jongh E, Snijders T, van Lammeren D, Beeker A, Herbers AHE, Tick L, Franken B, Veeger NJGM, van Roon EN, Hoogendoorn M. PMID: 42659837 [PubMed - as supplied by publisher]
	Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers. Lancet Haematol El-Galaly TC, Buvat I, Córdoba R, Porta MGD, Geissler J, Haddad TC, Jacobsen M, Kobbe G, McGowan ML, Sarkozy C, Thanarajasingam G, Villa D. PMID: 42660134 [PubMed - indexed for MEDLINE]
	Redefining Fitness in Chronic Lymphocytic Leukemia: A Treatment-Specific Framework forthe Targeted Therapy Era. Oncology Al-Asa Apos D Y, Alshemmari SH, Qasem NM, Al Battah A, Yassin MA. PMID: 42658749 [PubMed - as supplied by publisher]
	TargetPrior: A miRNA-Signature Embedded Evolutionary Learning Framework for Prioritizing Drug Targets in Acute Myeloid Leukemia. Bioinformatics Chen TY, Ho SY. PMID: 42658031 [PubMed - as supplied by publisher]
	Cardiac Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With First-Line Ibrutinib-Venetoclax. Eur J Haematol Hofstetter L, Buchrits S, Sherban A, Sternbach N, Raanani P, Zadok OIB, -Gvili AG, Itchaki G. PMID: 42657500 [PubMed - as supplied by publisher]
	Effectiveness and Safety of Imatinib and Nilotinib in Chronic Myeloid Leukemia: A Single-Center Study From Southern Morocco. Cureus El Mousadik M, El Khayat H, El Hizazi L, Bounar O, Halloumi O, Fatima Ezzahra R, Chakri I, Bouqoufi A, Lahlou L, Fares S. PMID: 42657079 [PubMed]

Articles 1 - 20 / 169953

Page 1 of 8498



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy